[61C1-61C1];[61C7-61C7];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
61C1;61C7
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3L)BSC798.
Inferred to overlap with: Df(3L)BSC247.
The presence of P+PBac{XP5.WH5}BSC362 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d07196 to be at Release 3 genomic coordinate 608800 on chromosome arm 3L. This corresponds to 61C7 on both the Release 3 and 5 genome maps. The predicted position of the progenitor PBac{WH}f03039 on the Release 5 map is 41C1. Consequently, the cytological breakpoints of Df(3L)BSC362 are predicted to be 61C1;61C7.